Lunit to Be Featured in 21 AI Imaging Studies on Breast Cancer and Lung Disease at ECR 2026

SEOUL, South Korea, March 4, 2026 /PRNewswire/ -- Lunit (KRX:32813), a leading provider of AI for cancer diagnostics and precision oncology, today announced that 21 studies featuring its AI solutions will be presented at the European Congress of Radiology 2026 (ECR 2026), taking place March 4-8 in Vienna, Austria.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.